![](https://scx1.b-cdn.net/csz/news/tmb/2018/finallyapote.jpg)
Finally, a potential new approach against KRAS-driven lung cancer
The previous decade has seen dramatic advances in the treatment of non-small cell lung cancer, as genes driving subtypes of the disease including EGFR, ALK, ROS1 and BRAF are paired with drugs that silence their action. However, ...
Aug 9, 2018
0
7